drugset / Trial / NCT03185143

Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea

NCT03185143

Phase 2/3 Completed 36 enrolled Allodynic Therapeutics, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This proof-of-concept study compares side-by-side low-dose naltrexone and acetaminophen combination to sumatriptan in the acute treatment of migraine.

Timeline

Start
2017-06-27
Primary completion
2018-05-07
Completion
2018-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject Naltrexone Small molecule
Comparator Sumatriptan Unknown 100 mg

Indications